Senior insider sale
General Counsel at NURIX THERAPEUTICS, INC. — senior position signals high conviction
$548.0K
33.05K shares
RING CHRISTINE plans to sell 33.05K shares of NURIX THERAPEUTICS, INC. valued at approximately $548.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
N/A
Employee Stock Purchase Plan
Cash
Previously Exercised Options
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/2/2022 | Restricted Stock Units N/A | 678.00 | — |
8/11/2020 | Employee Stock Purchase Plan Cash | 4.05K | — |
10/1/2019 | Previously Exercised Options Cash | 3.42K | — |
| Total | 8.15K | ||
Completed
Units to sell
3.37K
Market value
$57.1K
Units to sell
4.78K
Market value
$81.1K
Units to sell
5.39K
Market value
$90.4K
Units to sell
3.21K
Market value
$53.5K
Units to sell
8.15K
Market value
$124.1K
Planned — Approximate Date
Units to sell
8.15K
Market value
$141.7K
Units
33.05K
Value
$548.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/4/2026 | 3.37K | $57.1K | — | Completed |
5/4/2026 | 4.78K | $81.1K | — | Completed |
5/1/2026 | 5.39K | $90.4K | — | Completed |
4/30/2026 | 3.21K | $53.5K | — | Completed |
4/2/2026 | 8.15K | $124.1K | — | Completed |
| Planned — Approximate Date | ||||
6/2/2026 | 8.15K | $141.7K | NASDAQ | Planned |
| Total | 33.05K | $548.0K | ||